博文
SCI投稿之投稿后作者要更改或增加署名
精选
|
文章投稿后因某些原因需要更改或增加署名， 这种情况应该如何谨慎处理呢？申请了之后，杂志社是会同意还是会不同意因此拒稿呢？下面就和大家分享这种情况三类通常的处理方式。
第一类
BMC 系列以外也有类似操作的杂志，如 Journal of Cellular Biochemistry。
案例二
李医生（化名）的文稿投稿 Journal of Cellular Biochemistry（ISSN: 0730-2312）被修回后，作者因为某些原因需要新增一位共同一作，查看了杂志官网， 关于 Correction to authorship( 修改作者信息 ) 有详细说明：In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics (https://authorservices.wiley.com/ ethics-guidelines/index.html#5) and the Committee on Publication Ethics’ guidance (https://publicationethics.org/authorship), Journal of Cellular Biochemistry will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form (https://authorservices.wiley. com/asset/Authorship-change-form_AS.pdf) and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. 因而作者按要求签署完成了 Request for Changes to a Journal Article Author List Form，说明了新增作者在修回阶段所做的贡献，系统提交后杂志社没有提出疑问，目前该篇文章已被该杂志接受。
杂志官网针对更改或增加署名没有明确说明该如何处理，则修回杂志社的时候在 Cover letter 里说明清楚作者的变更及理由（如有新增作者说明该作者在修回阶段对文稿所做贡献），之后杂志社会来信告知具体需要如何处理，按照杂志社要求提供相关资料发回即可。
刘医生（化名）的文稿投稿 Annals of Medicine（ISSN: 0785-3890）被修回后，作者因为某些原因需要新增一位第三作者，由于没有在该杂志网站看到具 体修改作者信息的操作，所以在修回杂志社的时候， 作者在 Cover letter 中做了详细说明，但很遗憾文章因此被拒稿了，杂志社意见“We received the second round reviewer comments and read your rebuttal letter together with the revised manuscript. We noticed that you added a new co-author to your manuscript after the first round of peer review process. This lead us to in-house evaluation as well as consultation with the ICMJE recommendations (www.icmje.org) to reconsider your submission. Therefore, as the outcome, I regret to inform you that we cannot consider your manuscript for publication in Annals of Medicine. Thank you for allowing us to review this work. I very much regret that the decision was a negative one.”该杂志并没有给作者继续解释及填写更改作者信息表的机会。 本文出自美捷登，如需转载请联系我们授权，并注明来源美捷登
以上是和大家分享的几类更改或增加署名常见处理方式及结局。大家可以看到，投稿后如果要更改或增加署名，杂志社一般不会直接同意，不同杂志对此的处理方式及态度不一，且一般文章接受后大多数杂志是不允许作者更改或增加署名的。因此 也提醒大家最好能在投稿前确定好作者署名及顺序，在投稿后尽量不要再做修改。
国际医学期刊编辑委员会（ICMJE; http://www.icmje.org/）明确定义了Authorship Criteria（作者标准），即作为文章作者需要满足的条件，SCI 期刊也遵循此准则。Authorship should be given upon meeting all 4 of the following criteria proposed (verbatim) by the International Committee of Medical Journal Editors (ICMJE; http://www.icmje.org/):
(1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work;
(2) Drafting the work or revising it critically for important intellectual content;
(3) Final approval of the version to be published;
(4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
文章在署名的时候，作者需要确认是否每位作者都同时满足如上 4 点达到了作为作者的要求，若没有则需要考虑将该作者放到 Acknowledgments（致谢）部分。
以上就是对投稿后作者要更改或增加署名的一些经验分享，希望能对大家有帮助，谢谢！
https://wap.sciencenet.cn/blog-475824-1348806.html
上一篇：熬夜，大脑会被吃掉？
下一篇：创新超越，勇攀高峰—— 美捷登隆重举行2022年半年度全体员工总结大会
